| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 215.64B | 213.38B | 192.63B | 177.11B | 167.76B |
| Gross Profit | 65.01B | 58.00B | 50.96B | 45.64B | 51.15B |
| EBITDA | 26.16B | 17.60B | 22.85B | 43.50B | 15.10B |
| Net Income | 13.65B | 7.96B | 9.07B | 13.64B | 221.00M |
Balance Sheet | |||||
| Total Assets | 358.13B | 325.56B | 296.23B | 286.60B | 298.96B |
| Cash, Cash Equivalents and Short-Term Investments | 44.58B | 36.71B | 32.30B | 48.80B | 29.36B |
| Total Debt | 133.63B | 107.21B | 81.05B | 89.34B | 147.46B |
| Total Liabilities | 197.90B | 183.56B | 169.94B | 170.84B | 204.76B |
| Stockholders Equity | 158.18B | 140.07B | 124.43B | 114.23B | 92.20B |
Cash Flow | |||||
| Free Cash Flow | 12.48B | -12.60B | 4.81B | 658.00M | -8.63B |
| Operating Cash Flow | 17.62B | -6.57B | 14.24B | 8.38B | 3.59B |
| Investing Cash Flow | 133.00M | -4.99B | -9.22B | 76.76B | -14.56B |
| Financing Cash Flow | -9.79B | 13.36B | -14.55B | -68.68B | 9.45B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ¥64.73B | 14.88 | ― | 2.79% | 2.85% | 3.17% | |
75 Outperform | ¥69.80B | 16.94 | ― | 3.95% | -1.67% | -4.39% | |
72 Outperform | ¥187.69B | 16.40 | 10.44% | 2.77% | 2.74% | 7.86% | |
70 Outperform | ¥149.70B | 11.89 | 8.17% | 2.04% | 1.48% | 58.59% | |
70 Outperform | ¥69.83B | 14.83 | ― | 3.09% | 6.35% | -34.20% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
55 Neutral | ¥13.20B | 242.29 | ― | 1.65% | 3.96% | ― |
Nikkiso Co., Ltd. announced that its board has approved a new three‑year medium‑term business plan, “NIKKISO 2028 – Toward a Healthier World,” to begin in the fiscal year ending December 2026. The plan follows the successful “Nikkiso 2025 Phase 2” program, during which restructuring of unprofitable operations and robust industrial demand lifted operating profit above the JPY 14.0 billion target.
The new plan is positioned as a milestone toward the group’s 2035 long‑term vision and reflects an environment of rising geopolitical risk and evolving market conditions. By seeking growth beyond existing business models and leveraging recovering aerospace and medical operations alongside its low‑carbon strengths, Nikkiso aims to secure sustainable expansion and reinforce its strategic position in key industrial and healthcare markets.
The most recent analyst rating on (JP:6376) stock is a Hold with a Yen1989.00 price target. To see the full list of analyst forecasts on Nikkiso Co., Ltd. stock, see the JP:6376 Stock Forecast page.
Nikkiso Co., Ltd. has approved the introduction of an Employee Stock Benefit Trust (J-ESOP) that will grant company shares and equivalent cash to employees of the parent company and its domestic subsidiaries under defined stock grant rules. The scheme, modeled on a U.S.-style ESOP and administered via a trust established with Mizuho Trust & Banking, is intended to align employee incentives with share price and business performance while funding share acquisitions in advance through trust contributions.
By linking compensation to equity performance, Nikkiso aims to deepen employees’ sense of ownership, strengthen engagement, and support execution of its “NIKKISO 2028 – Toward a Healthier World” medium-term plan. The company expects the plan to reinforce efforts to improve profitability and share value, thereby potentially enhancing its competitive positioning and creating closer economic alignment between employees and shareholders over the coming years.
The most recent analyst rating on (JP:6376) stock is a Hold with a Yen1989.00 price target. To see the full list of analyst forecasts on Nikkiso Co., Ltd. stock, see the JP:6376 Stock Forecast page.
Nikkiso Co., Ltd. has approved a year-end dividend of ¥22 per share for the fiscal year ended December 31, 2025, up from its prior forecast of ¥18 and last year’s ¥15, bringing the total annual dividend to ¥40 per share. The increase reflects the company’s achievement of its operating profit target under the “Nikkiso 2025 Phase 2” plan, supported by higher overall profitability and expansion in its core businesses.
Alongside the dividend hike, Nikkiso issued a dividend forecast of ¥50 per share for the fiscal year ending December 31, 2026, split evenly between interim and year-end payments. Under its new medium-term plan “NIKKISO 2028 – Toward a Healthier World,” the company has adopted a progressive dividend policy tied to improving earnings, targeting a dividend-on-equity ratio of about 2.5% by 2028 and around 3% over the longer term to enhance shareholder returns.
The most recent analyst rating on (JP:6376) stock is a Hold with a Yen1989.00 price target. To see the full list of analyst forecasts on Nikkiso Co., Ltd. stock, see the JP:6376 Stock Forecast page.
Nikkiso Co., Ltd. reported modest revenue growth but a sharp rebound in profitability for the fiscal year ended 31 December 2025, with revenue up 1.1% to ¥215.6 billion and operating profit surging 139.6% to ¥15.3 billion. Profit attributable to owners of the parent jumped 71.6% to ¥13.7 billion, lifting basic earnings per share to ¥206.22 and improving margins and return on equity, while operating cash flow swung to a positive ¥17.6 billion and cash and cash equivalents rose to ¥44.6 billion.
The company strengthened its balance sheet, with total assets increasing to ¥358.1 billion and equity attributable to owners climbing to ¥158.2 billion, raising the equity ratio to 44.2%. Reflecting improved performance, Nikkiso raised its annual dividend for 2025 to ¥40 per share from ¥30 and is forecasting a further increase to ¥50 in 2026, while guiding for 2026 revenue growth of 8.3% but a slight year-on-year decline in profit attributable to owners as margins normalize and the group’s scope of consolidation is streamlined by the exclusion of eight companies.
The most recent analyst rating on (JP:6376) stock is a Hold with a Yen1989.00 price target. To see the full list of analyst forecasts on Nikkiso Co., Ltd. stock, see the JP:6376 Stock Forecast page.
Nikkiso Co., Ltd. is contesting a tax reassessment imposed under Japan’s controlled foreign company tax rules on three overseas subsidiaries within its Clean Energy & Industrial Gases Group, which impacted fiscal 2018 income at subsidiary Nikkiso International Co., Ltd. After losing challenges before the National Tax Tribunal, Tokyo District Court and Tokyo High Court, the board has resolved to escalate the case by filing an appeal and petition for acceptance to the Supreme Court on February 10, 2026.
The company has already booked and paid about ¥1.7 billion in corporate income tax related to this dispute in the fiscal year ended December 31, 2021, so it expects no impact on results for the year ending December 31, 2026 under current assumptions. However, Nikkiso acknowledges that the eventual Supreme Court outcome could affect earnings in 2026 or later periods, leaving some financial and legal uncertainty for shareholders and other stakeholders until the litigation is finally resolved.
The most recent analyst rating on (JP:6376) stock is a Hold with a Yen1989.00 price target. To see the full list of analyst forecasts on Nikkiso Co., Ltd. stock, see the JP:6376 Stock Forecast page.
Nikkiso Co., Ltd. has lost its appeal at the Tokyo High Court over a tax reassessment related to Japan’s Controlled Foreign Company (CFC) tax regime, concerning three foreign subsidiaries within its Clean Energy & Industrial Gases Group. Tax authorities had previously determined that these subsidiaries did not meet CFC exemption requirements, triggering a reassessment of fiscal 2018 business income at Nikkiso International Co., Ltd. and subsequent penalties. After an unfavorable ruling from the National Tax Tribunal and the Tokyo District Court, the High Court has now also dismissed Nikkiso’s claims, leaving the reassessment in place. The company expressed regret and indicated it finds the decisions difficult to accept, and it will scrutinize the ruling and consider its next steps, signaling potential ongoing legal or administrative responses and continued uncertainty for stakeholders until a final course of action is determined.
The most recent analyst rating on (JP:6376) stock is a Hold with a Yen1922.00 price target. To see the full list of analyst forecasts on Nikkiso Co., Ltd. stock, see the JP:6376 Stock Forecast page.
Nikkiso Co., Ltd. has announced a slate of director and Audit & Supervisory Board candidates to be submitted for approval at its 85th Ordinary General Meeting of Shareholders on March 27, 2026, signalling a measured refresh of its governance structure while maintaining continuity in top management. Representative Director, President and CEO Koichi Kato and several incumbent directors, including independent outside directors, are nominated for reelection, while Executive Officer and Head of Corporate Unit Masaharu Murakami is set to join the board as a new director and Hiroaki Asakura, currently a director and general manager at the company’s Chinese dialysis equipment affiliate, is nominated as a new Audit & Supervisory Board member. The company is also reappointing Naoshi Ogasawara as an outside Audit & Supervisory Board member and maintaining Makoto Suzuki as a substitute outside Audit & Supervisory Board member, while Chairman and Director Toshihiko Kai and Audit & Supervisory Board Member Motohiro Takeuchi are scheduled to retire on March 27, 2026, underscoring an orderly leadership transition and a continued emphasis on outside oversight in its governance framework.
The most recent analyst rating on (JP:6376) stock is a Hold with a Yen1695.00 price target. To see the full list of analyst forecasts on Nikkiso Co., Ltd. stock, see the JP:6376 Stock Forecast page.
Nikkiso Co., Ltd. announced a series of officer appointments and role confirmations effective January 1, 2026, as approved by its Board of Directors. The resolution largely maintains continuity in top management, with President and CEO Koichi Kato and key business heads in the medical, industrial, aerospace, corporate, and R&D units retaining their current positions, while formalizing Executive Officer status for Kazuhiko Sugimoto as head of the Medical Factory at the Kanazawa Plant. The move underscores organizational stability across Nikkiso’s main business segments and reinforces its governance structure as it continues to manage its diversified portfolio, including its U.S.-based cryogenic subsidiary, without signaling major strategic or operational shifts for stakeholders.
The most recent analyst rating on (JP:6376) stock is a Buy with a Yen1766.00 price target. To see the full list of analyst forecasts on Nikkiso Co., Ltd. stock, see the JP:6376 Stock Forecast page.
Nikkiso Co., Ltd. announced the completion of a share repurchase transaction, acquiring 1,000,000 shares for 1,544,000,000 yen through the Tokyo Stock Exchange’s ToSTNeT-3 system. This move aims to enhance shareholder returns and improve capital efficiency, reflecting the company’s strategic focus on optimizing its financial structure and delivering value to its stakeholders.
The most recent analyst rating on (JP:6376) stock is a Buy with a Yen1780.00 price target. To see the full list of analyst forecasts on Nikkiso Co., Ltd. stock, see the JP:6376 Stock Forecast page.
Nikkiso Co., Ltd. has announced a share repurchase plan as part of its strategy to enhance capital efficiency and provide stable returns to shareholders. The company plans to buy back up to 1,000,000 shares, representing 1.51% of its outstanding shares, at a total cost of up to 1,544,000,000 yen. This move aligns with their medium-term business plan, aiming for a total payout ratio of 35% by 2025, and reflects their commitment to improving business profitability and shareholder value.
The most recent analyst rating on (JP:6376) stock is a Buy with a Yen1780.00 price target. To see the full list of analyst forecasts on Nikkiso Co., Ltd. stock, see the JP:6376 Stock Forecast page.
Nikkiso Co., Ltd. reported a modest increase in revenue for the nine months ending September 30, 2025, with significant improvements in operating profit and profit before tax compared to the previous year. The company also announced a dividend increase, reflecting its positive financial outlook and stable market position, despite excluding six subsidiaries from its consolidation scope.
The most recent analyst rating on (JP:6376) stock is a Buy with a Yen1780.00 price target. To see the full list of analyst forecasts on Nikkiso Co., Ltd. stock, see the JP:6376 Stock Forecast page.